Vagstad Anna L, Lakis Edgars, Csizi Katja-Sophia, Walls William, Richter Daniel, Soo Lee Kang, Stocker Roman, Gugger Muriel, Broderick William E, Broderick Joan B, Reiher Markus, Piel Jörn
Institute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093, Zurich, Switzerland.
Institute of Molecular Physical Science, Eidgenössische Technische Hochschule (ETH) Zürich, 8093, Zurich, Switzerland.
Angew Chem Int Ed Engl. 2025 Feb 3;64(6):e202418054. doi: 10.1002/anie.202418054. Epub 2025 Jan 10.
Radical S-adenosyl methionine enzymes catalyze a diverse repertoire of post-translational modifications in protein and peptide substrates. Among these, an exceptional and mechanistically obscure example is the installation of α-keto-β-amino acid residues by formal excision of a tyrosine-derived tyramine unit. The responsible spliceases are key maturases in a widespread family of natural products termed spliceotides that comprise potent protease inhibitors, with the installed β-residues being crucial for bioactivity. Here, we established the in vitro activity of the model splicease PcpXY to interrogate the mechanism of non-canonical protein splicing. Identification of shunt and coproducts, deuterium labeling studies, and density functional theory energy calculations of hypothesized intermediates support a mechanism involving hydrogen abstraction at tyrosine Cα as the initial site of peptide radical formation and release of 4-hydroxybenzaldehyde as the tyrosine-derived coproduct. The data illuminate key features of this unprecedented radical-mediated biotransformation yielding ketoamide pharmacophores that are also present in peptidomimetic therapeutics.
自由基S-腺苷甲硫氨酸酶催化蛋白质和肽底物中多种翻译后修饰。其中,一个特殊且机制不明的例子是通过正式切除酪氨酸衍生的酪胺单元来安装α-酮-β-氨基酸残基。负责的剪接酶是一类广泛存在的天然产物(称为剪接核苷酸)中的关键成熟酶,这些天然产物包含有效的蛋白酶抑制剂,所安装的β-残基对生物活性至关重要。在此,我们确定了模型剪接酶PcpXY的体外活性,以探究非经典蛋白质剪接的机制。对旁路产物和副产物的鉴定、氘标记研究以及假设中间体的密度泛函理论能量计算支持了一种机制,该机制涉及在酪氨酸Cα处夺取氢作为肽自由基形成的初始位点,并释放4-羟基苯甲醛作为酪氨酸衍生的副产物。这些数据阐明了这种前所未有的自由基介导的生物转化产生酮酰胺药效团的关键特征,这些特征也存在于拟肽疗法中。